We conducted an economic analysis to assess the extent to which a reduction in adverse drug reactions induced by low osmolality compared with high osmolality contrast media during diagnostic angiocardiography would result in savings to hospitals, society and third-party payers that would offset the substantially higher price of low osmolality contrast medium.
Substitution of low osmolality for high osmolality contrast media in the approximately 1 million diagnostic angiocardiograpbic procedures performed each year in the United States could substantially increase health care costs.
Costeffectiveness estimates should include savings that might occur through reduced costs of managing adverse drug reactions.
Mots-clés Pascal : Angiocardiographie, Produit contraste, Exploration, Radiodiagnostic, Homme, Osmolarité, Coût, Aspect économique
Mots-clés Pascal anglais : Angiocardiography, Contrast media, Exploration, Radiodiagnosis, Human, Osmolarity, Costs, Economic aspect
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 93-0489326
Code Inist : 002B24A03. Création : 199406.